Home > Analyses > Technology > Genpact Limited
Genpact revolutionizes how global businesses manage complex processes, transforming data into decisive action. As a titan in IT and business process outsourcing, it serves banking, healthcare, manufacturing, and more with innovative digital solutions and deep domain expertise. With a reputation for quality and agility, Genpact shapes operational efficiency worldwide. The key question now: does its strong market position translate into sustainable growth and justify its current valuation?
Table of contents
Business Model & Company Overview
Genpact Limited, founded in 1997 and headquartered in Hamilton, Bermuda, stands as a leader in Information Technology Services. It integrates business process outsourcing with digital transformation to serve sectors including banking, consumer goods, and high tech. Its extensive workforce of 145K employees powers a cohesive ecosystem that enhances operational efficiency and innovation worldwide.
The company’s revenue engine balances finance and accounting services with IT and transformation offerings. It commands strong positions across the Americas, Europe, and Asia, delivering recurring value through consulting, analytics, and ESG solutions. Genpact’s competitive advantage lies in its deep domain expertise and global scale, which fortify its economic moat and shape the future of process-driven technology services.
Financial Performance & Fundamental Metrics
I will analyze Genpact Limited’s income statement, key financial ratios, and dividend payout policy to reveal its core financial health and shareholder returns.
Income Statement
This table summarizes Genpact Limited’s key income statement figures for fiscal years 2021 through 2025, reported in USD.
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue | 4.02B | 4.37B | 4.48B | 4.77B | 5.08B |
| Cost of Revenue | 2.59B | 2.83B | 2.91B | 3.08B | 3.27B |
| Operating Expenses | 923M | 1.03B | 940M | 988M | 1.05B |
| Gross Profit | 1.43B | 1.54B | 1.57B | 1.69B | 1.81B |
| EBITDA | 709M | 653M | 773M | 853M | 875M |
| EBIT | 541M | 523M | 669M | 756M | 780M |
| Interest Expense | 58M | 58M | 66M | 80M | 50M |
| Net Income | 369M | 353M | 631M | 514M | 552M |
| EPS | 1.97 | 1.92 | 3.46 | 2.88 | 3.18 |
| Filing Date | 2022-03-01 | 2023-03-01 | 2024-02-29 | 2025-03-03 | 2026-02-26 |
Income Statement Evolution
Genpact’s revenue grew 26.3% from 2021 to 2025, with a 6.56% increase in 2025 alone. Net income surged 49.55% over the period, yet only rose 7.5% in 2025. Margins improved steadily: gross margin reached 35.57%, net margin 10.88%, both reflecting enhanced profitability and cost control. EBITDA and EBIT margins remain favorable and stable.
Is the Income Statement Favorable?
In 2025, Genpact posted $5.08B revenue and $552M net income, with a 10.88% net margin signaling solid profitability. Operating expenses rose proportionally with revenue, maintaining margin stability. Interest expense stayed low at 0.98% of revenue. EPS grew 9.82%, confirming earnings strength. Overall, fundamentals appear favorable with balanced growth and efficient cost management.
Financial Ratios
The following table summarizes key financial ratios for Genpact Limited over the last five fiscal years, providing a clear view of profitability, liquidity, leverage, and valuation metrics:
| Ratios | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Margin | 9.2% | 8.1% | 14.1% | 10.8% | 10.9% |
| ROE | 19.5% | 19.4% | 28.1% | 21.5% | 21.7% |
| ROIC | 9.4% | 10.2% | 15.8% | 13.0% | 12.3% |
| P/E | 27.0 | 24.1 | 10.0 | 14.9 | 14.7 |
| P/B | 5.3 | 4.7 | 2.8 | 3.2 | 3.2 |
| Current Ratio | 1.47 | 1.61 | 1.44 | 2.16 | 1.66 |
| Quick Ratio | 1.47 | 1.61 | 1.44 | 2.16 | 1.66 |
| D/E | 1.05 | 0.93 | 0.67 | 0.60 | 0.74 |
| Debt-to-Assets | 40.2% | 37.0% | 31.3% | 29.0% | 32.4% |
| Interest Coverage | 8.7 | 8.6 | 9.5 | 8.8 | 15.3 |
| Asset Turnover | 0.81 | 0.95 | 0.93 | 0.96 | 0.87 |
| Fixed Asset Turnover | 7.7 | 10.8 | 11.4 | 11.7 | 13.6 |
| Dividend Yield | 0.81% | 1.08% | 1.58% | 1.42% | 1.45% |
Evolution of Financial Ratios
Genpact’s Return on Equity (ROE) remained strong, peaking near 28% in 2023 before stabilizing around 21.7% in 2025. The Current Ratio showed volatility, climbing from 1.44 in 2023 to 2.16 in 2024, then settling at 1.66 in 2025. Debt-to-Equity fluctuated moderately, peaking above 1.05 in 2021 and moderating near 0.74 in 2025. Profitability margins have generally held steady with slight compressions in recent years.
Are the Financial Ratios Favorable?
In 2025, profitability metrics like net margin (10.9%) and ROE (21.7%) are favorable, outperforming typical sector benchmarks. Liquidity ratios, including the current and quick ratios near 1.66, indicate healthy short-term resilience. Leverage ratios are neutral; debt-to-equity at 0.74 and debt-to-assets around 32% suggest moderate risk. Market valuation shows mixed signals: a reasonable PE ratio (14.7) contrasts with an unfavorable price-to-book ratio (3.19). Overall, the ratio profile leans favorable but warrants attention to leverage and valuation nuances.
Shareholder Return Policy
Genpact Limited maintains a consistent dividend payout ratio around 21%, with dividends per share rising steadily from $0.43 in 2021 to $0.68 in 2025. The annual dividend yield hovers near 1.4%, supported by free cash flow coverage exceeding 90%, indicating prudent capital allocation.
The company engages in share buybacks alongside dividend payments, balancing returns with reinvestment needs. This disciplined distribution approach supports sustainable long-term value creation by aligning shareholder returns with operational cash flow and profitability metrics.
Score analysis
The radar chart below presents a comprehensive view of Genpact Limited’s key financial scores across valuation, profitability, and leverage metrics:
Genpact scores very favorably in discounted cash flow (5) and shows favorable returns on equity (4) and assets (4). However, it faces a significant red flag with a very unfavorable debt-to-equity score (1). Valuation metrics are moderate to unfavorable, with P/E at 3 and P/B at 2.
Analysis of the company’s bankruptcy risk
Genpact’s Altman Z-Score places it comfortably in the safe zone, indicating a low risk of bankruptcy based on its financial ratios:
Is the company in good financial health?
The Piotroski diagram illustrates Genpact’s strong financial health with a solid score of 7 points:
A Piotroski score of 7 suggests robust financial strength, reflecting good profitability, liquidity, and operational efficiency, which supports confidence in the company’s financial stability.
Competitive Landscape & Sector Positioning
This analysis explores Genpact Limited’s strategic positioning, revenue segments, and key products within the technology sector. We will assess its main competitors and identify competitive advantages in the evolving market landscape. I will evaluate whether Genpact maintains a sustainable edge over its peers.
Strategic Positioning
Genpact Limited maintains a diversified product portfolio across banking, consumer healthcare, and high tech sectors. Its geographic exposure centers on India, generating over 3B revenue in 2025, with significant operations in Americas, Asia (excluding India), and Europe.
Revenue by Segment
This pie chart presents Genpact Limited’s revenue breakdown by segment for fiscal year 2025, highlighting the company’s primary sources of income.
Genpact’s revenue in 2025 is driven solely by the Consumer And Healthcare segment, generating $1.7B. This focus marks a shift from earlier years when multiple segments contributed, indicating a concentration risk. Historically, diverse revenue streams like Banking, High Tech, and Business Process Outsourcing supported growth. The recent data suggests strategic consolidation or reporting changes, warranting close monitoring of segment diversification going forward.
Key Products & Brands
The table below outlines Genpact Limited’s primary products and brands based on its service segments:
| Product | Description |
|---|---|
| Banking, Capital Markets and Insurance | Services include CFO advisory, finance and accounting, enterprise risk and compliance, and ESG reporting tailored to financial firms. |
| Consumer Goods, Retail, Life Sciences and Healthcare | Provides finance, accounting, supply chain advisory, and after-sales services to consumer and healthcare sectors. |
| High Tech, Manufacturing and Services | Offers sourcing, procurement, sales and commercial services, and IT infrastructure management for technology and manufacturing firms. |
| Business Process Outsourcing (BPO) | Encompasses document management, invoice processing, order management, and related outsourcing services. |
| Information Technology Services (IT) | Includes end-user computing support, infrastructure management, application support, and digital transformation services. |
Genpact’s product portfolio spans critical business process and IT services. Its offerings target financial, consumer, healthcare, technology, and manufacturing sectors, reflecting broad industry coverage and diversified revenue streams.
Main Competitors
There are 16 competitors in total, with the table below listing the top 10 leaders by market capitalization:
| Competitor | Market Cap. |
|---|---|
| International Business Machines Corporation | 272B |
| Accenture plc | 162B |
| Cognizant Technology Solutions Corporation | 40B |
| Fiserv, Inc. | 36B |
| Fidelity National Information Services, Inc. | 34B |
| Wipro Limited | 30B |
| Leidos Holdings, Inc. | 23B |
| Gartner, Inc. | 18B |
| CDW Corporation | 17B |
| Jack Henry & Associates, Inc. | 13B |
Genpact Limited ranks 12th among 16 competitors, with a market cap just 2.5% that of the sector leader, IBM. It sits below both the average market cap of the top 10 competitors (approximately 64.6B) and the sector median (17.8B). The company enjoys a 62.5% market cap lead over its closest rival above, highlighting a notable gap.
Comparisons with competitors
Check out how we compare the company to its competitors:
Does Genpact have a competitive advantage?
Genpact demonstrates a sustainable competitive advantage, evidenced by a ROIC exceeding WACC by over 6% and a growing ROIC trend of 31% from 2021 to 2025. This strong value creation signals efficient capital use and consistent profitability.
Looking ahead, Genpact’s broad geographic presence and diversified services—including CFO advisory and ESG solutions—position it well to capture growth in emerging markets and evolving IT service demands. Expansion in India and Asia drives future revenue opportunities.
SWOT Analysis
This analysis highlights Genpact Limited’s key internal and external factors shaping its competitive position.
Strengths
- strong ROIC well above WACC
- diversified global footprint with growth in India
- favorable profit margins and solid cash flow generation
Weaknesses
- relatively high price-to-book ratio signals possible overvaluation
- moderate debt levels limit financial flexibility
- slower revenue growth in key regions like Americas
Opportunities
- expanding ESG and digital transformation services
- rising demand for outsourced finance and IT services
- geographic expansion in emerging markets
Threats
- intense competition in IT services sector
- currency fluctuations impacting international revenue
- evolving regulatory and compliance risks
Genpact’s sustainable competitive advantage and strong profitability provide a solid foundation. However, cautious capital allocation and strategic focus on growth markets are essential to mitigate risks and capitalize on emerging opportunities.
Stock Price Action Analysis
The weekly stock chart for Genpact Limited (G) over the past 12 months reveals significant price movements and volatility, highlighting key resistance and support levels:
Trend Analysis
Over the past 12 months, the stock price increased by 24.94%, indicating a bullish trend. The price peaked at 55.05 and bottomed at 30.9, with volatility measured by a 5.85 standard deviation. Recently, from December 2025 to March 2026, the trend reversed with a -17.27% decline, showing deceleration and a negative slope of -1.0.
Volume Analysis
Total volume is increasing, with buyer volume at 463M and seller volume at 432M, indicating slight buyer dominance overall (51.09%). However, in the recent period ending March 2026, sellers dominate with 63M volume versus buyers’ 49M, signaling cautious or bearish sentiment among investors.
Target Prices
Analysts present a solid target consensus for Genpact Limited, indicating moderate upside potential.
| Target Low | Target High | Consensus |
|---|---|---|
| 42 | 50 | 46 |
The target range between $42 and $50 reflects cautious optimism. The consensus of $46 suggests steady growth expectations in the near term.
Don’t Let Luck Decide Your Entry Point
Optimize your entry points with our advanced ProRealTime indicators. You’ll get efficient buy signals with precise price targets for maximum performance. Start outperforming now!
Analyst & Consumer Opinions
This section examines recent analyst grades and consumer feedback to gauge market sentiment on Genpact Limited (G).
Stock Grades
Here are the latest verified stock grades for Genpact Limited from reputable analysts and grading firms:
| Grading Company | Action | New Grade | Date |
|---|---|---|---|
| Mizuho | Maintain | Neutral | 2026-02-10 |
| Needham | Maintain | Buy | 2026-02-06 |
| JP Morgan | Maintain | Neutral | 2025-08-20 |
| Needham | Maintain | Buy | 2025-08-08 |
| Mizuho | Maintain | Neutral | 2025-07-01 |
| Needham | Maintain | Buy | 2025-06-30 |
| TD Cowen | Maintain | Buy | 2025-06-27 |
| Needham | Maintain | Buy | 2025-05-08 |
| Baird | Maintain | Neutral | 2025-05-08 |
| Mizuho | Maintain | Neutral | 2025-02-10 |
The consensus reveals a steady split between Neutral and Buy ratings, with no Sell or Strong Buy recommendations. This pattern suggests cautious optimism among analysts, favoring a Hold consensus overall.
Consumer Opinions
Genpact Limited inspires mixed reactions from its user base, revealing key insights into service quality and client expectations.
| Positive Reviews | Negative Reviews |
|---|---|
| “Excellent process optimization and strong client support.” | “Response times can be slow during peak hours.” |
| “Innovative use of AI boosts efficiency across projects.” | “Occasional miscommunication in project details.” |
| “Reliable delivery with consistent quality improvements.” | “Pricing feels premium compared to competitors.” |
Overall, consumers praise Genpact’s innovation and reliable service delivery. However, delays and communication issues surface as common concerns, suggesting areas for operational improvements.
Risk Analysis
Below is a table summarizing key risks for Genpact Limited, including their likelihood and potential impact:
| Category | Description | Probability | Impact |
|---|---|---|---|
| Market Volatility | Exposure to cyclical IT services demand and macroeconomic fluctuations | Medium | High |
| Debt Levels | Moderate leverage with debt-to-equity concerns despite strong coverage | Medium | Medium |
| Valuation | Elevated price-to-book ratio suggests potential overvaluation risks | Medium | Medium |
| Competitive Pressure | Intense competition in IT and BPO sectors could erode margins | High | High |
| Regulatory & ESG | Increasing ESG compliance costs and regulatory scrutiny globally | Medium | Medium |
The most pressing risks stem from intense sector competition and macroeconomic sensitivity. Genpact’s safe Altman Z-score (3.09) and strong Piotroski score (7) mitigate bankruptcy concerns. However, its unfavorable price-to-book ratio (3.19) signals valuation caution amid rising market volatility.
Should You Buy Genpact Limited?
Genpact appears to be delivering improving profitability with a durable competitive moat supported by growing ROIC well above WACC. Despite substantial leverage reflected in debt metrics, its overall B+ rating suggests a very favorable profile for value creation and operational efficiency.
Strength & Efficiency Pillars
Genpact Limited exhibits robust operational efficiency with a net margin of 10.88% and a return on equity (ROE) of 21.67%, signaling solid profitability. Its return on invested capital (ROIC) stands at 12.32%, comfortably above the weighted average cost of capital (WACC) of 6.15%. This clear spread confirms the company as a value creator. Additionally, the firm’s growing ROIC trend underlines a sustainable competitive advantage and improving profitability, reinforcing its very favorable moat status.
Weaknesses and Drawbacks
Genpact’s valuation presents cautionary signs. Its price-to-book ratio of 3.19 is unfavorable, suggesting the stock trades at a premium relative to book value. While the debt-to-equity ratio of 0.74 is neutral, it highlights moderate leverage that investors should monitor amid market volatility. Recent trading shows a slightly seller-dominant environment with buyer dominance at 43.93%, indicating short-term selling pressure despite an overall bullish trend. These factors could weigh on near-term price appreciation.
Our Final Verdict about Genpact Limited
Genpact’s fundamental profile appears attractive for long-term exposure, supported by solid profitability and value creation. However, despite the overall bullish stock trend, the recent seller-dominant behavior suggests investors might adopt a wait-and-see stance to seek a more favorable entry point. The company’s strong financial health and moat provide confidence, but prudence in timing remains essential amid market fluctuations.
Disclaimer: This content is for informational purposes only and does not constitute financial, investment, or other professional advice. Investing in financial markets involves a significant risk of loss, and past performance is not indicative of future results.
Additional Resources
- Decoding Genpact Ltd (G): A Strategic SWOT Insight – GuruFocus (Feb 27, 2026)
- Vanguard Group Inc. Reduces Stock Position in Genpact Limited $G – MarketBeat (Feb 24, 2026)
- Here’s Why Genpact (G) is a Strong Growth Stock – Yahoo Finance (Feb 25, 2026)
- Genpact LTD SEC 10-K Report – TradingView (Feb 26, 2026)
- New US Tariffs and Trade Uncertainty Could Be A Game Changer For Genpact’s (G) AI Shift – simplywall.st (Feb 26, 2026)
For more information about Genpact Limited, please visit the official website: genpact.com
